MannKind Corporation (MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension,
WESTLAKE VILLAGE, Calif., Feb. 20, 2020 -- MannKind Corporation (NASDAQ: MNKD) today announced the presentation of results from multiple clinical studies of Afrezza® (insulin.
MannKind Corporation (MNKD) will release its 2019 fourth quarter and full year financial results and its management will host a conference call to discuss the financial results and corporate updates a
In 2017 Michael Castagna was appointed CEO of MannKind Corporation (NASDAQ:MNKD). This analysis aims first to contrast...

3 Top-Notch “Strong Buy” Stocks Under $3

09:37am, Monday, 20'th Jan 2020
If you’re on a budget, yet in a risk-tolerant mood, it’s worth taking a look at penny stocks – companies whose shares sell for less than $5 apiece. Here you get a lot more for your money; For ex

3 Top-Notch "Strong Buy" Stocks Under $3

09:33am, Monday, 20'th Jan 2020
If you’re on a budget, yet in a risk-tolerant mood, it’s worth taking a look at penny stocks – companies whose shares sell for less than $5 apiece. Here

Top Picks 2020- MannKind MNKD

10:00am, Friday, 10'th Jan 2020
Given how things are shaping up for MannKind (MNKD) as we begin 2020, it is once again my Top Pick for speculative investors in the coming year, suggests Nate Pile, editor of Nate's Notes.
MannKind Corporation (MNKD) announced today that its Brazilian partner, Biomm S.A., has received written notice from the Chamber of Regulation of the Medicines Market (CMED) approving the proposed p
Newcomers to the stock market often dream of fast profits but don’t have large investing accounts. Then they hear about this thing called “penny stocks.”
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE